Azar says Trump administration negotiating to buy more Pfizer vaccines after passing on earlier offer

Health and Human Services Secretary Alex Azar told reporters Wednesday that U.S. officials "are engaged in active negotiations" with Pfizer to purchase more of the company's COVID-19 vaccines, per Politico. The comment seemingly backs up an earlier report from The New York Times, in which anonymous sources familiar with the matter said the same thing.

The Trump administration this summer reportedly turned down an offer to expand on the initial order to buy more than 100 million vaccine doses, and Pfizer went on to strike agreements with other governments, including the European Union. That raised some questions stateside, though it seems the administration was hedging its bets since several other vaccine candidates have appeared promising, as well.

The shot developed by Pfizer and BioNTech was the first rolled out in the U.S., however, and there is widespread confidence in its efficacy and safety, so it seems the White House is working to enhance its supply after all. Read more at Politico.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up